2012年

November 7, 2012: Consolidated Financial Results (For the Second Quarter Ended september 30,2012)- Supplementary Information
November 7, 2012: Summary of Consolidated Financial Results (For the Second Quarter Ended september 30,2012)［Japanese Standard］
October 9, 2012: Announcement regarding transfer of "Pekiron Cream 0.5%" topical antifungal medication business.
September 25, 2012: Application filed for KRP-108, an Anti-asthmatic Treatment, in Japan
July 31, 2012: Summary of Consolidated Financial Results(For the First Quarter Ended June 30, 2012)
July 31, 2012: First Quarter Consolidated Financial Results for the Fiscal Year Ending March 31, 2013
May 28, 2012: Establishment of a Subsidiary
May 28, 2012: Announcement Regarding Transfer/Acquisition of MSD Shiga Plant
May 9, 2012: Financial Results for the Fiscal 2011, the Year Ended March 31, 2012- Supplementary Information
May 9, 2012: Summary of Consolidated Financial Results(For the fiscal year ended March 31, 2012)
April 20, 2012: Launch of "AIPHAGANR Ophthalmic Solution 0.1%" for the treatment of Glaucoma / Ocular Hypertension, in Japan
February 3, 2012: Third Quarter Consolidated Financial Results for the Ending Fiscal Year March 31, 2012
February 3, 2012: Summary of Consolidated Financial Results(For the Third Quarter Ended December 31, 2011) [Japanese Standard]